findmyKOL
Clinical trialNCT00559949CompletedPhase 2Interventional

Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine

SponsorNational Cancer Institute (NCI)Enrollment39Recurrent Thyroid Gland CarcinomaStage I Thyroid Gland Papillary CarcinomaStage II Thyroid Gland Papillary CarcinomaStage III Thyroid Gland Papillary CarcinomaStage IV Thyroid Gland Papillary Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University Health Network-Princess Margaret Hospital

    Toronto, Ontario, Canada

United States
  • Moffitt Cancer Center

    Tampa, Florida, United States

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

  • Unc Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, United States

  • Vanderbilt University/ingram Cancer Center

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2007
Primary completion
31 Aug 2016
Completion
31 Aug 2016
Last update posted
30 Jan 2017
Registered enrollment
39
Registry id
NCT00559949
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.